These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 21675720)

  • 1. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine.
    Ambrogio MW; Thomas CR; Zhao YL; Zink JI; Stoddart JF
    Acc Chem Res; 2011 Oct; 44(10):903-13. PubMed ID: 21675720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.
    Caldorera-Moore ME; Liechty WB; Peppas NA
    Acc Chem Res; 2011 Oct; 44(10):1061-70. PubMed ID: 21932809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlocked systems in nanomedicine.
    Ornelas-Megiatto C; Becher TB; Megiatto JD
    Curr Top Med Chem; 2015; 15(13):1236-56. PubMed ID: 25858133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanised nanoparticles for drug delivery.
    Cotí KK; Belowich ME; Liong M; Ambrogio MW; Lau YA; Khatib HA; Zink JI; Khashab NM; Stoddart JF
    Nanoscale; 2009 Oct; 1(1):16-39. PubMed ID: 20644858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica nanoparticles as cutting-edge theranostics: Advancement from merely a carrier to tailor-made smart delivery platform.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    J Control Release; 2018 Oct; 287():35-57. PubMed ID: 30125637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
    Song Y; Li Y; Xu Q; Liu Z
    Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Mesoporous Silica Nanoparticles for Targeted Drug Delivery Applications.
    Abu-Dief AM; Alsehli M; Al-Enizi A; Nafady A
    Curr Drug Deliv; 2022; 19(4):436-450. PubMed ID: 34238185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances.
    Ghaferi M; Koohi Moftakhari Esfahani M; Raza A; Al Harthi S; Ebrahimi Shahmabadi H; Alavi SE
    J Drug Target; 2021 Feb; 29(2):131-154. PubMed ID: 32815741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica nanoparticles in nanomedicine applications.
    Manzano M; Vallet-Regí M
    J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized mesoporous silica nanoparticles in anticancer therapeutics.
    Barkat A; Beg S; Panda SK; S Alharbi K; Rahman M; Ahmed FJ
    Semin Cancer Biol; 2021 Feb; 69():365-375. PubMed ID: 31442571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theragnostic potentials of core/shell mesoporous silica nanostructures.
    Ravindran Girija A; Balasubramanian S
    Nanotheranostics; 2019; 3(1):1-40. PubMed ID: 30662821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.
    Chen F; Hableel G; Zhao ER; Jokerst JV
    J Colloid Interface Sci; 2018 Jul; 521():261-279. PubMed ID: 29510868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles.
    Zhao YL; Li Z; Kabehie S; Botros YY; Stoddart JF; Zink JI
    J Am Chem Soc; 2010 Sep; 132(37):13016-25. PubMed ID: 20799689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
    Giret S; Wong Chi Man M; Carcel C
    Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.